Literature DB >> 31121327

Laparoscopic sleeve gastrectomy versus laparoscopic gastric bypass: A retrospective cohort study.

Mohit Bhandari1, Manoj Reddy2, Susmit Kosta3, Winni Mathur4, Mathias Fobi5.   

Abstract

BACKGROUND: There are many reports on short-term outcomes following sleeve gastrectomy, which demonstrate that it has comparable efficacy to gastric bypass. However, there are very few long-term comparative reports. This study compared the outcomes from laparoscopic sleeve gastrectomy (LSG) and laparoscopic gastric bypass (LGB) in a cohort of patients who had surgery in 2011 with a six-year follow up.
MATERIALS AND METHODS: Data on patients who had either LSG or LGB at a single centre in Mohak Bariatric and Robotic Surgery Centre, Indore, M.P. India in 2011 were identified from a database of routinely collected data. This retrospective cohort was analysed for weight loss, resolution of comorbidities and nutritional status over six years. Patients who had revision operations or for whom six-year follow-up data were not available were excluded from the analysis.
RESULTS: 154 patients had LGB and 152 had LSG. The six-year follow up rate was 61.7% (n = 95) and 64.5% (n = 98) respectively for LGB and LSG. Percentage of excess bodyweight loss (%EWL) peaked at approximately 70% after two years in the LSG group and after three years in the LGB group. However, after six years %EWL was 61% for LGB and 50% for LSG (p = 0.001). Resolution of type-2 diabetes was more common in the LGB group compared to the LSG group (79% vs 62%, p = 0.126). Resolution of hypertension and dyslipidaemia was similar in both groups at approximately half of patients in each group for each condition. Nutrient deficiencies were found in both groups but were generally more pronounced in the LGB group.
CONCLUSION: LGB is a better operation for weight loss, weight loss maintenance, and resolution of type-2 diabetes than LSG. This is at the expense of an increased incidence of nutrient deficiencies. LSG appears to have greater treatment failure by six years follow up and this should be further investigated.
Copyright © 2019 IJS Publishing Group Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Gastric bypass; Laparoscopic surgery; Sleeve gastrectomy; Weight loss

Mesh:

Year:  2019        PMID: 31121327     DOI: 10.1016/j.ijsu.2019.05.004

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  5 in total

1.  Comparison of Laparoscopic Roux-en-Y Gastric Bypass and Laparoscopic Sleeve Gastrectomy on Weight Loss, Weight Regain, and Remission of Comorbidities: A 5 Years of Follow-up Study.

Authors:  Karamollah Toolabi; Maryam Sarkardeh; Mahtab Vasigh; Mahdieh Golzarand; Payam Vezvaei; Javad Kooshki
Journal:  Obes Surg       Date:  2020-02       Impact factor: 4.129

2.  Laparoscopic Roux-en-Y Gastric Bypass and Laparoscopic Sleeve Gastrectomy in Terms of Efficacy and Safety: a Comparative Study During 11-Year Experience.

Authors:  Karamollah Toolabi; Mahdieh Golzarand; Roya Farid
Journal:  Obes Surg       Date:  2021-03-08       Impact factor: 4.129

3.  Laparoscopic Roux-en-Y Gastric Bypass Versus Sleeve Gastrectomy for Type 2 Diabetes Mellitus in Nonseverely Obese Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Yanhua Sha; Xianzhang Huang; Peifeng Ke; Bailin Wang; Hui Yuan; Wei Yuan; Yongliang Wang; Xuanjin Zhu; Yong Yan
Journal:  Obes Surg       Date:  2020-05       Impact factor: 4.129

Review 4.  Vitamin B Complex Deficiency After Roux-en-Y Gastric Bypass and Sleeve Gastrectomy-a Systematic Review and Meta-Analysis.

Authors:  Rita Nunes; Hugo Santos-Sousa; Sofia Vieira; Jorge Nogueiro; Raquel Bouça-Machado; André Pereira; Silvestre Carneiro; André Costa-Pinho; Eduardo Lima-da-Costa; John Preto; C R I-O Group
Journal:  Obes Surg       Date:  2022-01-04       Impact factor: 4.129

5.  Toll-like receptor 4 and myeloid differentiation factor 88 are required for gastric bypass-induced metabolic effects.

Authors:  Marwa Abu El Haija; Yuanchao Ye; Yi Chu; Hussein Herz; Benjamin Linden; Shailesh K Shahi; Kasra Zarei; Ashutosh K Mangalam; Steven J Mcelroy; Mohamad Mokadem
Journal:  Surg Obes Relat Dis       Date:  2021-08-02       Impact factor: 3.709

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.